English  |  正體中文  |  简体中文  |  2817371  
???header.visitor??? :  27734159    ???header.onlineuser??? :  378
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"park keunchil"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-9 of 9  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-01-05T01:19:23Z Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial Park, Keunchil; Özgüroğlu, Mustafa; Vansteenkiste, Johan; Spigel, David; CHIH-HSIN YANG; Ishii, Hidenobu; Garassino, Marina; de Marinis, Filippo; Szczesna, Aleksandra; Polychronis, Andreas; Uslu, Ruchan; Krzakowski, Maciej; Lee, Jong-Seok; Calabrò, Luana; Arén Frontera, Osvaldo; Xiong, Huiling; Bajars, Marcis; Ruisi, Mary; Barlesi, Fabrice
臺大學術典藏 2021-01-18T09:12:07Z Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY Nishio, Makoto; Seto, Takashi; Reck, Martin; Garon, Edward B.; Chiu, Chao Hua; Yoh, Kiyotaka; Imamura, Fumio; Park, Keunchil; JIN-YUAN SHIH; Visseren-Grul, Carla; Frimodt-Moller, Bente; Zimmermann, Annamaria; Homma, Gosuke; Enatsu, Sotaro; Nakagawa, Kazuhiko
國立成功大學 2016-10 Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer Scagliotti, Giorgio;Kang, Jin Hyoung;Smith, David;Rosenberg, Richard;Park, Keunchil;Kim, Sang-We;Su, Wu-Chou;Boyd, Thomas E.;Richards, Donald A.;Novello, Silvia;Hynes, Scott M.;Myrand, Scott P.;Lin, Ji;Smyth, Emily Nash;Wijayawardana, Sameera;Lin, Aimee Bence;Pinder-Schenck, Mary
國立成功大學 2016-10 A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma Mok, Tony Shu Kam; Geater, Sarayut Lucien; Su, Wu-Chou; Tan, Eng-Huat; Yang, James Chi-Hsin; Chang, Gee-Chen; Han, May; Komarnitsky, Philip; Payumo, Francis; Garrus, Jennifer E.; Close, Sandra; Park, Keunchil
國立臺灣大學 2015 A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results. Yang, James Chih-Hsin; Srimuninnimit, Vichien; Ahn, Myung-Ju; Lin, Chia-Chi; Kim, Sang-We; Tsai, Chun-Ming; Mok, Tony; Orlando, Mauro; Puri, Tarun; Wang, Xin; Park, Keunchil; 林家齊; 楊志新
國立臺灣大學 2015 TIGER-1: A Phase 2/3 Study of First Line Rociletinib or Erlotinib in EGFR-Mutant NSCLC Camidge, Ross; Cappuzzo, Federico; Go, Jowell; Isaacson, Jeffrey; Litten, Jason; Park, Keunchil; Spigel, David R.; Spira, Alexander; Vergnenegre, Alain; Wolf, Juergen; Yang, James Chih-Hsin; Mok, Tony; 楊志新
國立臺灣大學 2015 Antitumor Activity of Tepotinib plus Gefitinib in Asian Patients with Met plus EGFRm plus NSCLC Kim, Dong-Wan; Soo, Ross; Yang, James Chih-Hsin; Park, Keunchil; Stammberger, Uz; Xiong, Huiiling; Ihling, Christian; Wu, Yi-Long; 楊志新
國立成功大學 2012-05 Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial Miller, Vincent A.; Hirsh, Vera; Cadranel, Jacques; Chen, Yuh-Min; Park, Keunchil; Kim, Sang-We; Zhou, Caicun; Su, Wu-Chou; Wang, Mengzhao; Sun, Yan; Heo, Dae Seog; Crino, Lucio; Tan, Eng-Huat; Chao, Tsu-Yi; Shahidi, Mehdi; Cong, Xiuyu Julie; Lorence, Robert M.; Yang, James Chih-Hsin
國立臺灣大學 2012 Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial Miller, Vincent A.; Hirsh, Vera; Cadranel, Jacques; Chen, Yuh-Min; Park, Keunchil; Kim, Sang-We; Zhou, Caicun; Su, Wu-Chou; Wang, Mengzhao; Sun, Yan; Heo, Dae Seog; Crino, Lucio; Tan, Eng-Huat; Chao, Tsu-Yi; Shahidi, Mehdi; Cong, Xiuyu Julie; Lorence, Robert M.; Yang, James Chih-Hsin; 楊志新

Showing items 1-9 of 9  (1 Page(s) Totally)
1 
View [10|25|50] records per page